Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Intensive Care Med ; 33(3): 503-10, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17219196

ABSTRACT

OBJECTIVE: Pneumonia is a frequent cause of acute respiratory distress syndrome (ARDS), and Pseudomonas aeruginosa is a leading pathogen in nosocomial pneumonia. The management of ARDS remains a major problem, and only a limited number of options can improve the oxygenation. Inhaled nitric oxide (iNO) has been widely used, although this molecule is a free radical potentially harmful through the generation of toxic radical derivatives. The goal of our study was to assess the consequences of iNO (10 ppm) in a rat model of P. aeruginosa-induced lung injury. DESIGN: The animals were exposed for 24 h to iNO after instillation of the pathogen. Distal alveolar fluid clearance (DAFC) and epithelial and endothelial permeability were measured with a double flux of radio-labeled albumin. RESULTS: DAFC and epithelial permeability were increased in pneumonia but not influenced by iNO. In contrast, endothelial permeability was statistically significantly higher in the pneumonic animals exposed to iNO than in the pneumonic group without iNO (0.24+/-0.03 vs 0.47+/-0.1, p<0.05). This increase was not related to the production of nitrate/nitrite, nor to the increase of the inflammatory response evaluated by cytokine levels in the bronchoalveolar lavage fluid (TNF-alpha, IL-6, IL-10). The alveolar recruitment of polymorphonuclear neutrophils was comparable in the pneumonic group exposed to iNO and the pneumonic group without iNO. CONCLUSION: iNO increases the endothelial permeability in P. aeruginosa pneumonia. The mechanism is not related to the production of nitrate/nitrite or to a greater inflammatory response.


Subject(s)
Bronchodilator Agents/pharmacology , Capillary Permeability/drug effects , Nitric Oxide/pharmacology , Pneumonia, Bacterial/drug therapy , Pseudomonas Infections/drug therapy , Respiratory Distress Syndrome/drug therapy , Administration, Inhalation , Animals , Bronchoalveolar Lavage Fluid/cytology , Bronchoalveolar Lavage Fluid/immunology , Bronchodilator Agents/therapeutic use , Cytokines/metabolism , Leukocyte Count , Neutrophils/metabolism , Nitric Oxide/therapeutic use , Pneumonia, Bacterial/complications , Pneumonia, Bacterial/metabolism , Pseudomonas Infections/complications , Pseudomonas Infections/metabolism , Pulmonary Alveoli/blood supply , Pulmonary Alveoli/drug effects , Pulmonary Alveoli/immunology , Rats , Rats, Sprague-Dawley , Respiratory Distress Syndrome/etiology , Respiratory Distress Syndrome/metabolism
2.
Intensive Care Med ; 30(6): 1204-11, 2004 Jun.
Article in English | MEDLINE | ID: mdl-14991100

ABSTRACT

OBJECTIVE: Pseudomonas aeruginosa-induced lung injury is characterized not only by the alteration in lung fluid movement but also by apoptosis of lung epithelial and endothelial cells. We studied whether inhibition of apoptosis using a broad spectrum caspase inhibitor, benzyloxycarbonyl-Val-Ala-Asp fluoromethylketone (Z-VAD.fmk), would affect lung fluid balance in rat P. aeruginosa pneumonia. METHODS: Z-VAD.fmk (3 mg/kg) was administered intravenously simultaneously with P. aeruginosa intratracheal instillation (0.5 ml/kg, 2 x 10(9) CFU/ml). Apoptosis was evaluated with the TUNEL technique, cytoplasmic oligonucleosome assay, and caspase 3 activation. To evaluate lung permeability, extravascular plasma equivalent (EPE) and lung wet to dry weight ratio (W/D) were measured 4 h after intratracheal instillation of P. aeruginosa. RESULTS: We found an increase of lung apoptosis 4 h after P. aeruginosa instillation: cytoplasmic oligonucleosome assay increased from 3.17+/-0.78 to 26.82+/-4.67 ODx1000/mg of proteins/ml, Z-VAD.fmk administration decreased this parameter to 10.3+/-2.98 ODx1000/mg of proteins/ml. Caspase 3 levels followed the same pattern. Apoptosis involved both epithelial cells and endothelial cells. Endothelial permeability was increased after Pseudomonas instillation: W/D increased from 3.75+/-0.28 in the Co group to 4.42+/-0.23 in the Pn group; EPE was also higher in the Pn group compared with the Co group (0.125+/-0.04 and 0.002+/-0.01 ml, respectively). Both of these parameters were improved after Z-VAD.fmk administration; W/D decreased to 3.36+/-0.25 and EPE to 0.02+/-0.02 ml. CONCLUSION: Apoptosis occurs in the early phase of P. aeruginosa pneumonia. Administration of Z-VAD.fmk significantly decreases DNA fragmentation and caspase 3 levels. This is associated with an improvement of endothelial permeability and lung fluid balance.


Subject(s)
Amino Acid Chloromethyl Ketones/pharmacology , Apoptosis/drug effects , Pseudomonas Infections/physiopathology , Pulmonary Edema/physiopathology , Respiratory Distress Syndrome/physiopathology , Animals , Apoptosis/physiology , Capillary Permeability/drug effects , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Pulmonary Alveoli/drug effects , Pulmonary Alveoli/metabolism , Rats , Rats, Sprague-Dawley , Statistics, Nonparametric
3.
Shock ; 19(6): 559-63, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12785012

ABSTRACT

Mechanical ventilation is associated with several harmful effects mainly related to high tidal volumes (Vt). Ventilator-induced lung injury can be responsible for an increased production of inflammatory mediators. We evaluated remote consequences on the gut of lung triggered inflammatory response, neutralizing anti-tumor necrosis factor (TNF) antibody was administered to assess the role of TNF in lung and gut permeability changes. Rats were anesthetized and ventilated for 2 h. A control group (Con: Vt = 10 mL/kg) was compared with a high Vt group (HV: Vt = 30 ml/kg). One microCi of I125-labeled human serum albumin was injected to measure extravascular albumin space. Gut permeability was evaluated by plasma-to-lumen ratio leakage of I125 human serum albumin. Extravascular albumin space increased in the HV group from 446 +/- 50 microL to 2783 +/- 887 microL. Gut index of permeability increased from 5.1 +/- 1.2 to 14.2 +/- 4.9. Anti-TNF antibody prevented both lung and gut increase in permeability. High tidal volume ventilation resulted in an increase in lung edema and gut permeability, antagonism of TNF with neutralizing antibodies abrogated the increase in gut permeability as well as lung edema.


Subject(s)
Antibodies/pharmacology , Cell Membrane Permeability/physiology , Gastrointestinal Motility/physiology , Respiration, Artificial/adverse effects , Respiratory Distress Syndrome/etiology , Tumor Necrosis Factor-alpha/immunology , Animals , Cell Membrane Permeability/drug effects , Disease Models, Animal , Gastrointestinal Motility/drug effects , Oxygen/blood , Partial Pressure , Rats , Rats, Sprague-Dawley , Respiratory Distress Syndrome/physiopathology , Tidal Volume
SELECTION OF CITATIONS
SEARCH DETAIL
...